- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.
According to our latest study, the global Submucosal Injection Agent market size was valued at USD 98.1 million in 2022 and is forecast to a readjusted size of USD 160.9 million by 2029 with a CAGR of 7.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.
This report is a detailed and comprehensive analysis for global Submucosal Injection Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Submucosal Injection Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Submucosal Injection Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Submucosal Injection Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Submucosal Injection Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Submucosal Injection Agent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Submucosal Injection Agent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals and Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Submucosal Injection Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Syringe Type
Ampoule Type
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Major players covered
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Submucosal Injection Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Submucosal Injection Agent, with price, sales, revenue and global market share of Submucosal Injection Agent from 2018 to 2023.
Chapter 3, the Submucosal Injection Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Submucosal Injection Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Submucosal Injection Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Submucosal Injection Agent.
Chapter 14 and 15, to describe Submucosal Injection Agent sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Submucosal Injection Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Submucosal Injection Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe Type
1.3.3 Ampoule Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Submucosal Injection Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Global Submucosal Injection Agent Market Size & Forecast
1.5.1 Global Submucosal Injection Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Submucosal Injection Agent Sales Quantity (2018-2029)
1.5.3 Global Submucosal Injection Agent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Seikagaku
2.1.1 Seikagaku Details
2.1.2 Seikagaku Major Business
2.1.3 Seikagaku Submucosal Injection Agent Product and Services
2.1.4 Seikagaku Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Seikagaku Recent Developments/Updates
2.2 Ovesco Endoscopy
2.2.1 Ovesco Endoscopy Details
2.2.2 Ovesco Endoscopy Major Business
2.2.3 Ovesco Endoscopy Submucosal Injection Agent Product and Services
2.2.4 Ovesco Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ovesco Endoscopy Recent Developments/Updates
2.3 GI Supply
2.3.1 GI Supply Details
2.3.2 GI Supply Major Business
2.3.3 GI Supply Submucosal Injection Agent Product and Services
2.3.4 GI Supply Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GI Supply Recent Developments/Updates
2.4 Cosmo Pharmaceuticals
2.4.1 Cosmo Pharmaceuticals Details
2.4.2 Cosmo Pharmaceuticals Major Business
2.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
2.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Submucosal Injection Agent Product and Services
2.5.4 Boston Scientific Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 The Standard
2.6.1 The Standard Details
2.6.2 The Standard Major Business
2.6.3 The Standard Submucosal Injection Agent Product and Services
2.6.4 The Standard Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 The Standard Recent Developments/Updates
2.7 Micro-Tech Endoscopy
2.7.1 Micro-Tech Endoscopy Details
2.7.2 Micro-Tech Endoscopy Major Business
2.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
2.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Micro-Tech Endoscopy Recent Developments/Updates
2.8 EndoClot Plus
2.8.1 EndoClot Plus Details
2.8.2 EndoClot Plus Major Business
2.8.3 EndoClot Plus Submucosal Injection Agent Product and Services
2.8.4 EndoClot Plus Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 EndoClot Plus Recent Developments/Updates
3 Competitive Environment: Submucosal Injection Agent by Manufacturer
3.1 Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023)
3.3 Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Submucosal Injection Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Submucosal Injection Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Submucosal Injection Agent Manufacturer Market Share in 2022
3.5 Submucosal Injection Agent Market: Overall Company Footprint Analysis
3.5.1 Submucosal Injection Agent Market: Region Footprint
3.5.2 Submucosal Injection Agent Market: Company Product Type Footprint
3.5.3 Submucosal Injection Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Submucosal Injection Agent Market Size by Region
4.1.1 Global Submucosal Injection Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Submucosal Injection Agent Consumption Value by Region (2018-2029)
4.1.3 Global Submucosal Injection Agent Average Price by Region (2018-2029)
4.2 North America Submucosal Injection Agent Consumption Value (2018-2029)
4.3 Europe Submucosal Injection Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029)
4.5 South America Submucosal Injection Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Submucosal Injection Agent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Submucosal Injection Agent Sales Quantity by Type (2018-2029)
5.2 Global Submucosal Injection Agent Consumption Value by Type (2018-2029)
5.3 Global Submucosal Injection Agent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Submucosal Injection Agent Sales Quantity by Application (2018-2029)
6.2 Global Submucosal Injection Agent Consumption Value by Application (2018-2029)
6.3 Global Submucosal Injection Agent Average Price by Application (2018-2029)
7 North America
7.1 North America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
7.2 North America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
7.3 North America Submucosal Injection Agent Market Size by Country
7.3.1 North America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Submucosal Injection Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Submucosal Injection Agent Sales Quantity by Type (2018-2029)
8.2 Europe Submucosal Injection Agent Sales Quantity by Application (2018-2029)
8.3 Europe Submucosal Injection Agent Market Size by Country
8.3.1 Europe Submucosal Injection Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Submucosal Injection Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Submucosal Injection Agent Market Size by Region
9.3.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
10.2 South America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
10.3 South America Submucosal Injection Agent Market Size by Country
10.3.1 South America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Submucosal Injection Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Submucosal Injection Agent Market Size by Country
11.3.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Submucosal Injection Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Submucosal Injection Agent Market Drivers
12.2 Submucosal Injection Agent Market Restraints
12.3 Submucosal Injection Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Submucosal Injection Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Submucosal Injection Agent
13.3 Submucosal Injection Agent Production Process
13.4 Submucosal Injection Agent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Submucosal Injection Agent Typical Distributors
14.3 Submucosal Injection Agent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Seikagaku Basic Information, Manufacturing Base and Competitors
Table 4. Seikagaku Major Business
Table 5. Seikagaku Submucosal Injection Agent Product and Services
Table 6. Seikagaku Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Seikagaku Recent Developments/Updates
Table 8. Ovesco Endoscopy Basic Information, Manufacturing Base and Competitors
Table 9. Ovesco Endoscopy Major Business
Table 10. Ovesco Endoscopy Submucosal Injection Agent Product and Services
Table 11. Ovesco Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ovesco Endoscopy Recent Developments/Updates
Table 13. GI Supply Basic Information, Manufacturing Base and Competitors
Table 14. GI Supply Major Business
Table 15. GI Supply Submucosal Injection Agent Product and Services
Table 16. GI Supply Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GI Supply Recent Developments/Updates
Table 18. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Cosmo Pharmaceuticals Major Business
Table 20. Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
Table 21. Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cosmo Pharmaceuticals Recent Developments/Updates
Table 23. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Major Business
Table 25. Boston Scientific Submucosal Injection Agent Product and Services
Table 26. Boston Scientific Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Boston Scientific Recent Developments/Updates
Table 28. The Standard Basic Information, Manufacturing Base and Competitors
Table 29. The Standard Major Business
Table 30. The Standard Submucosal Injection Agent Product and Services
Table 31. The Standard Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. The Standard Recent Developments/Updates
Table 33. Micro-Tech Endoscopy Basic Information, Manufacturing Base and Competitors
Table 34. Micro-Tech Endoscopy Major Business
Table 35. Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
Table 36. Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Micro-Tech Endoscopy Recent Developments/Updates
Table 38. EndoClot Plus Basic Information, Manufacturing Base and Competitors
Table 39. EndoClot Plus Major Business
Table 40. EndoClot Plus Submucosal Injection Agent Product and Services
Table 41. EndoClot Plus Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. EndoClot Plus Recent Developments/Updates
Table 43. Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Submucosal Injection Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Submucosal Injection Agent Production Site of Key Manufacturer
Table 48. Submucosal Injection Agent Market: Company Product Type Footprint
Table 49. Submucosal Injection Agent Market: Company Product Application Footprint
Table 50. Submucosal Injection Agent New Market Entrants and Barriers to Market Entry
Table 51. Submucosal Injection Agent Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Submucosal Injection Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Submucosal Injection Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Submucosal Injection Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Submucosal Injection Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Submucosal Injection Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Submucosal Injection Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Submucosal Injection Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Submucosal Injection Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Submucosal Injection Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Submucosal Injection Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Submucosal Injection Agent Raw Material
Table 111. Key Manufacturers of Submucosal Injection Agent Raw Materials
Table 112. Submucosal Injection Agent Typical Distributors
Table 113. Submucosal Injection Agent Typical Customers
List of Figures
Figure 1. Submucosal Injection Agent Picture
Figure 2. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Submucosal Injection Agent Consumption Value Market Share by Type in 2022
Figure 4. Syringe Type Examples
Figure 5. Ampoule Type Examples
Figure 6. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Submucosal Injection Agent Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Ambulatory Surgical Centers Examples
Figure 10. Specialty Clinics Examples
Figure 11. Global Submucosal Injection Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Submucosal Injection Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Submucosal Injection Agent Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Submucosal Injection Agent Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Submucosal Injection Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Submucosal Injection Agent Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Submucosal Injection Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Submucosal Injection Agent Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Submucosal Injection Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Submucosal Injection Agent Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Submucosal Injection Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 53. China Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Submucosal Injection Agent Market Drivers
Figure 74. Submucosal Injection Agent Market Restraints
Figure 75. Submucosal Injection Agent Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Submucosal Injection Agent in 2022
Figure 78. Manufacturing Process Analysis of Submucosal Injection Agent
Figure 79. Submucosal Injection Agent Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
